Eurasian Harm Reduction Association (EHRA) would like to inform initiative groups and organizations of the community of people who use psychoactive substances, as well as organizations working in drug policy and harm reduction field in CEECA region, about the possibility of receiving resource assistance/funding for the activities, related to the advocacy of new harm reduction approaches in the region.
The assistance is provided by the Secretariat of EHRA as part of the project “We Will Not End AIDS Until We Adopt Harm Reduction and End the War on Drugs” of the International Harm Reduction Consortium, which now involves eight international and regional networks of people who use drugs and harm reduction and drug policy organizations, such as International Drug Policy Consortium (IDPC), European Network of People who Use Drugs (EuroNPUD), Eurasian Drug Users Network (ENPUD), Youth RISE, Harm Reduction International (HRI), Middle East and North Africa Harm Reduction Association (MENAHRA), Eurasian Harm Reduction Association (EHRA), and Women and Harm Reduction International Network (WHRIN). The Harm Reduction Consortium exists to challenge the global war on drugs (the critical factor affecting the rights of people who use drugs), to scale-up access to HIV-related harm reduction services, and to advocate for greater resources for harm reduction.
In 2019, EHRA developed “Criminalization Costs” pocket guide, which was created to advise on advocacy of reallocating funds from law enforcement budgets to health and harm reduction budgets for people who use psychoactive substances. This guide is supplementary to the “Criminalization Costs” assessment. In the end of 2019, experts meeting on introduction and promotion of new harm reduction approaches in CEECA region was held in Vilnius, in order to understand how particular harm reduction services working in European countries can be introduced and promoted in CEECA region.
Thus, Eurasian Harm Reduction Association would like to offer its assistance by providing small grants, 2 days training and ongoing technical assistance, related to advocacy of humane drug policy and new harm reduction approaches in your country.